United States · Venture startup

Who invested in Gravity Diagnostics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

HealthcareMedical Devices

Funding summaryUpdated 26 Oct 2026

$5.0Mraised across 1 round since 2025, from 1 source

Latest round
Venture, $5.0MFeb 2025
Investors
1
See who backed them

The rounds

  1. Feb 2025
    Venture$5.0M

    Source recorded

Founders and team

From Gravity Diagnostics's own website: 1 founder, 8 on the team.

Julie BrazilChief Operating Officer & Co-Founder
  • Bryan WhislerVice President of Revenue Cycle Management
  • Jaclyn TrentVice President of Sales
  • Adam CaswellChief of External Affairs
  • Allison HallChief of Staff
  • Karen HargettChief People Officer
  • Mike TarwaterChief Technology Officer
  • Nick LykteyChief of Laboratory Operations
  • Chris RobertsVP of Strategic Initiatives

Everyone who backed them

Advantage CapitalCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Gravity Diagnostics

Who invested in Gravity Diagnostics?

Gravity Diagnostics's investors include Advantage Capital.

How much has Gravity Diagnostics raised?

Gravity Diagnostics has raised $5.0M across 1 round since 2025.

When did Gravity Diagnostics last raise?

Gravity Diagnostics's most recent round was a Venture of $5.0M in Feb 2025.

What was Gravity Diagnostics's biggest round?

Its most recent round, $5.0M in Feb 2025, is also its largest on record.

Who backed Gravity Diagnostics first?

Gravity Diagnostics's first round on record, in Feb 2025, was backed by Advantage Capital.

What stage is Gravity Diagnostics at?

Gravity Diagnostics's latest named round is a Venture, in Feb 2025.

Where is Gravity Diagnostics based?

Gravity Diagnostics is based in the United States.

Companies like Gravity Diagnostics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.